Services that support your weight loss journey
At iCRYO, we understand that every individual's weight loss journey is unique. Our medical professionals create personalized plans tailored to your specific needs, ensuring optimal results and support every step of the way.
At iCRYO, we understand that every individual's weight loss journey is unique. Our medical professionals create personalized plans tailored to your specific needs, ensuring optimal results and support every step of the way.
Medical Weight Loss is a prescribed injection to help in losing stubborn fat. iCRYO offers Semaglutide and Tirzepatide for guests with a BMI of 27 or higher. Semaglutide and Tirzepatide are revolutionary medications that have been proven to significantly aid in weight loss by regulating appetite and improving metabolic health.
iCRYO offers a monthly medical weight loss pass to help boost your weight loss and get your health goals on track.
See how the process looks below:
Beginning
Your pass will begin with four consecutive weeks with 1 injection per week at a beginning dosage.
Dosage Strength
After four weeks, you will have a consultation to determine what the best dosage strength for you.
Weight Goal Achieved
After reaching your weight loss goal, the dosage will remain the same to maintain your new image.
Maintain Weight
After the first 5 months, you can choose to continue with the maintenance dosage. This will help to maintain your new weight month-to-month.
Schedule you free consultation and get started today!
Up to 20% Weight Reduction
Reclaim your health and confidence and lose up to 20%* of your body weight.
Regulate Appetite
Our Medical Weight Loss Options help regulate your appetite by reducing cravings , thus contributing towards your overall weight management.
Boost Your Weight Loss
Achieve your goals faster and healthier, by combining healthy eating and exercise into your routine.
Frequently Asked Questions
Semaglutide is a prescription injection that aids weight loss. It mimics a hormone used to regulate areas of the brain involved in appetite and food intake.
Tirzepatide, is a prescribed injection that aids in weight loss. It is a dual GIP and GLP-1 receptor agonist. This means it not only helps control your appetite but also enhances insulin sensitivity, leading to more effective weight loss.
Yes, both products have been FDA approved for chronic weight management. Semaglutide was approved in 2021 and Tirzepatide was approved in 2023.
Semaglutide is a GLP-1 receptor agonist. It works by mimicking a hormone in your body that helps regulate appetite and blood sugar levels, and it slows down how quickly your stomach empties, making you feel fuller longer.
Tirzepatide mimics the actions of two hormones, GLP-1 and GIP, which together stimulate insulin secretion and slow stomach emptying after a meal. Additionally, it sends a signal to the brain to induce a feeling of fullness and helps regulate fat cells.
Our Medical Weight Loss is meant for guests with a BMI of 27 or above, that suffer from weight related health issues. Schedule your free consultation today to find out if this is the right fit for you.
Do you have a specific question?
Call an iCRYO Health Expert near you.
Frequently Asked Questions
Semaglutide is a prescription injection that aids weight loss. It mimics a hormone used to regulate areas of the brain involved in appetite and food intake.
Semaglutide is a GLP-1 receptor agonist. It works by mimicking a hormone in your body that helps regulate appetite and blood sugar levels, and it slows down how quickly your stomach empties, making you feel fuller longer.
Tirzepatide, is a prescribed injection that aids in weight loss. It is a dual GIP and GLP-1 receptor agonist. This means it not only helps control your appetite but also enhances insulin sensitivity, leading to more effective weight loss.
Tirzepatide mimics the actions of two hormones, GLP-1 and GIP, which together stimulate insulin secretion and slow stomach emptying after a meal. Additionally, it sends a signal to the brain to induce a feeling of fullness and helps regulate fat cells.
Our Medical Weight Loss is meant for guests with a BMI of 27 or above, that suffer from weight related health issues. Schedule your free consultation today to find out if this is the right fit for you.
Yes, both products have been FDA approved for chronic weight management. Semaglutide was approved in 2021 and Tirzepatide was approved in 2023.
Do you have a specific question?
Talk to a real person at location near you.
Rated 4.8 of 5 | 10,000+ Reviews
Get started on your health journey
Why wait? We've made the process easy, so you can start bettering your health today.
New Guest Expectations
Here is everything you should expect on your first visit to iCRYO.
Download iCRYO App
Easily book and reschedule appointments with the iCRYO app.
Common side effects include:
- Nausea
- Vomiting
- Headache
- Dyspepsia
- Abdominal Pain
- GERD
- Alopecia
- Diarrhea
- Constipation
- Fatigue
- Dizziness
- Flatulence
- Gastritis
- Injection Site Reaction
Use with caution if you have:
- Suicidal History
- Volume Depletion (Dehydration)
- Diabetes Miletus
- Renal Impairment
- Pancreatitis
- Diabetic Retinopathy
Do not take Semaglutide if:
- You Are Pregnant
- Have Medullary Thyroid History
- Have Hypersensitivity
- Multiple Endocrine Neoplasias
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional. You may report side effects to the FDA at 1-800-FDA-1088.
*Average weight loss for Tirzepatide is 20.6%, results may vary.